61 related articles for article (PubMed ID: 7643449)
1. [The expression pattern of transcription factors (GATA, SCL) and biological characteristics in various leukemia cells].
Shimamoto T; Ohyashiki JH; Ohyashiki K; Toyama K
Rinsho Ketsueki; 1995 Jun; 36(6):547-51. PubMed ID: 7643449
[TBL] [Abstract][Full Text] [Related]
2. The expression pattern of erythrocyte/megakaryocyte-related transcription factors GATA-1 and the stem cell leukemia gene correlates with hematopoietic differentiation and is associated with outcome of acute myeloid leukemia.
Shimamoto T; Ohyashiki K; Ohyashiki JH; Kawakubo K; Fujimura T; Iwama H; Nakazawa S; Toyama K
Blood; 1995 Oct; 86(8):3173-80. PubMed ID: 7579412
[TBL] [Abstract][Full Text] [Related]
3. GATA-1, GATA-2, and stem cell leukemia gene expression in acute myeloid leukemia.
Shimamoto T; Ohyashiki JH; Ohyashiki K; Kawakubo K; Kimura N; Nakazawa S; Toyama K
Leukemia; 1994 Jul; 8(7):1176-80. PubMed ID: 8035609
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the relationship between Scl transcription factor complex protein expression patterns and the effects of LiCl on ATRA-induced differentiation in blast cells from patients with acute myeloid leukemia.
Rice AM; Holtz KM; Karp J; Rollins S; Sartorelli AC
Leuk Res; 2004 Nov; 28(11):1227-37. PubMed ID: 15380350
[TBL] [Abstract][Full Text] [Related]
5. Regulation of lineage restricted haemopoietic transcription factors in cell hybrids.
Murrell AM; Green AR
Oncogene; 1995 Feb; 10(4):631-9. PubMed ID: 7862440
[TBL] [Abstract][Full Text] [Related]
6. Control of erythroid cell production via caspase-mediated cleavage of transcription factor SCL/Tal-1.
Zeuner A; Eramo A; Testa U; Felli N; Pelosi E; Mariani G; Srinivasula SM; Alnemri ES; Condorelli G; Peschle C; De Maria R
Cell Death Differ; 2003 Aug; 10(8):905-13. PubMed ID: 12867998
[TBL] [Abstract][Full Text] [Related]
7. GATA-and SP1-binding sites are required for the full activity of the tissue-specific promoter of the tal-1 gene.
Lecointe N; Bernard O; Naert K; Joulin V; Larsen CJ; Romeo PH; Mathieu-Mahul D
Oncogene; 1994 Sep; 9(9):2623-32. PubMed ID: 8058326
[TBL] [Abstract][Full Text] [Related]
8. Expression of GATA-1 mRNA in human myeloid leukemic cells.
Guerrasio A; Saglio G; Rosso C; Alfarano A; Camaschella C; Lo Coco F; Biondi A; Rambaldi A; Nicolis S; Ottolenghi S
Leukemia; 1994 Jun; 8(6):1034-8. PubMed ID: 8207977
[TBL] [Abstract][Full Text] [Related]
9. GATA-1 and erythropoietin receptor genes are highly expressed in erythroleukemia.
Komatsu N; Kirito K; Izumi T; Eguchi M; Miura Y
Exp Hematol; 1998 Nov; 26(12):1148-54. PubMed ID: 9808054
[TBL] [Abstract][Full Text] [Related]
10. SCL expression at critical points in human hematopoietic lineage commitment.
Zhang Y; Payne KJ; Zhu Y; Price MA; Parrish YK; Zielinska E; Barsky LW; Crooks GM
Stem Cells; 2005; 23(6):852-60. PubMed ID: 15917481
[TBL] [Abstract][Full Text] [Related]
11. Chromatin immunoselection defines a TAL-1 target gene.
Cohen-Kaminsky S; Maouche-Chrétien L; Vitelli L; Vinit MA; Blanchard I; Yamamoto M; Peschle C; Roméo PH
EMBO J; 1998 Sep; 17(17):5151-60. PubMed ID: 9724651
[TBL] [Abstract][Full Text] [Related]
12. Transcription of the SCL gene in erythroid and CD34 positive primitive myeloid cells is controlled by a complex network of lineage-restricted chromatin-dependent and chromatin-independent regulatory elements.
Göttgens B; McLaughlin F; Bockamp EO; Fordham JL; Begley CG; Kosmopoulos K; Elefanty AG; Green AR
Oncogene; 1997 Nov; 15(20):2419-28. PubMed ID: 9395238
[TBL] [Abstract][Full Text] [Related]
13. GATA1, cytidine deaminase, and the high cure rate of Down syndrome children with acute megakaryocytic leukemia.
Ge Y; Stout ML; Tatman DA; Jensen TL; Buck S; Thomas RL; Ravindranath Y; Matherly LH; Taub JW
J Natl Cancer Inst; 2005 Feb; 97(3):226-31. PubMed ID: 15687366
[TBL] [Abstract][Full Text] [Related]
14. Constitutive expression of the putative transcription factor SCL associated with proviral insertion in the myeloid leukemic cell line WEHI-3BD-.
Tanigawa T; Robb L; Green AR; Begley CG
Cell Growth Differ; 1994 Jun; 5(6):557-61. PubMed ID: 8086334
[TBL] [Abstract][Full Text] [Related]
15. Expression pattern of WT1 and GATA-1 in AML with chromosome 16q22 abnormalities.
Patmasiriwat P; Fraizer GC; Claxton D; Kantarjian H; Saunders GF
Leukemia; 1996 Jul; 10(7):1127-33. PubMed ID: 8683991
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of Gata-1, Gata-2, EKLF, and c-MPL expression in acute myeloid leukemia.
Ayala RM; Martínez-López J; Albízua E; Diez A; Gilsanz F
Am J Hematol; 2009 Feb; 84(2):79-86. PubMed ID: 19097174
[TBL] [Abstract][Full Text] [Related]
17. Increased dosage of Runx1/AML1 acts as a positive modulator of myeloid leukemogenesis in BXH2 mice.
Yanagida M; Osato M; Yamashita N; Liqun H; Jacob B; Wu F; Cao X; Nakamura T; Yokomizo T; Takahashi S; Yamamoto M; Shigesada K; Ito Y
Oncogene; 2005 Jun; 24(28):4477-85. PubMed ID: 15856017
[TBL] [Abstract][Full Text] [Related]
18. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
Lo Coco F; Pisegna S; Diverio D
Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
[TBL] [Abstract][Full Text] [Related]
19. Pattern of expression and their clinical implications of the GATA family, stem cell leukemia gene, and EVI1 in leukemia and myelodysplastic syndromes.
Ohyashiki K; Ohyashiki JH; Shimamoto T; Toyama K
Leuk Lymphoma; 1996 Nov; 23(5-6):431-6. PubMed ID: 9031072
[TBL] [Abstract][Full Text] [Related]
20. [Diagnosis of stem cell leukemias in view of phenotypic and genotypic analysis].
Kawakami K; Ikeda T; Kita K; Shirakawa S
Rinsho Ketsueki; 1991 Jun; 32(6):618-22. PubMed ID: 1890737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
